全文获取类型
收费全文 | 1710509篇 |
免费 | 129263篇 |
国内免费 | 5872篇 |
专业分类
耳鼻咽喉 | 22024篇 |
儿科学 | 55810篇 |
妇产科学 | 46470篇 |
基础医学 | 242899篇 |
口腔科学 | 49211篇 |
临床医学 | 153966篇 |
内科学 | 334578篇 |
皮肤病学 | 38956篇 |
神经病学 | 131744篇 |
特种医学 | 64863篇 |
外国民族医学 | 258篇 |
外科学 | 258984篇 |
综合类 | 43741篇 |
现状与发展 | 11篇 |
一般理论 | 536篇 |
预防医学 | 125368篇 |
眼科学 | 40834篇 |
药学 | 126348篇 |
25篇 | |
中国医学 | 6094篇 |
肿瘤学 | 102924篇 |
出版年
2021年 | 12860篇 |
2019年 | 14538篇 |
2018年 | 21001篇 |
2017年 | 16266篇 |
2016年 | 17570篇 |
2015年 | 20291篇 |
2014年 | 27956篇 |
2013年 | 39518篇 |
2012年 | 55004篇 |
2011年 | 57819篇 |
2010年 | 34265篇 |
2009年 | 31897篇 |
2008年 | 53081篇 |
2007年 | 56314篇 |
2006年 | 56667篇 |
2005年 | 53961篇 |
2004年 | 51723篇 |
2003年 | 49010篇 |
2002年 | 47041篇 |
2001年 | 92288篇 |
2000年 | 93963篇 |
1999年 | 77143篇 |
1998年 | 19149篇 |
1997年 | 16598篇 |
1996年 | 16664篇 |
1995年 | 16914篇 |
1994年 | 15459篇 |
1993年 | 14170篇 |
1992年 | 57487篇 |
1991年 | 55416篇 |
1990年 | 53066篇 |
1989年 | 50838篇 |
1988年 | 46216篇 |
1987年 | 44996篇 |
1986年 | 42260篇 |
1985年 | 40033篇 |
1984年 | 29330篇 |
1983年 | 24870篇 |
1982年 | 13845篇 |
1979年 | 25482篇 |
1978年 | 17534篇 |
1977年 | 14854篇 |
1976年 | 13835篇 |
1975年 | 14517篇 |
1974年 | 17606篇 |
1973年 | 16912篇 |
1972年 | 15666篇 |
1971年 | 14436篇 |
1970年 | 13419篇 |
1969年 | 12505篇 |
排序方式: 共有10000条查询结果,搜索用时 14 毫秒
41.
42.
43.
44.
Ana Paula Valverde erson Camargo Ana L cia S Rodrigues 《World Journal of Psychiatry》2021,11(11):981-996
Major depressive disorder (MDD) is a disabling and highly prevalent mood disorder as well as a common cause of suicide. Chronic stress, inflammation, and intestinal dysbiosis have all been shown to play crucial roles in the patho physiology of MDD. Although conventional antidepressants are widely used in the clinic, they can take weeks to months to produce therapeutic effects. The discovery that ketamine promotes fast and sustaining antidepressant responses is one of the most important breakthroughs in the pharmacotherapy of MDD. However, the adverse psychomimetic/dissociative and neurotoxic effects of ketamine discourage its chronic use. Therefore, agmatine, an endogenous glutamatergic modulator, has been postulated to elicit fast behavioral and synaptogenic effects by stimulating the mechanistic target of rapamycin complex 1 signaling pathway, similar to ketamine. However, recent evidence has demonstrated that the modulation of the NLR family pyrin domain containing 3 inflammasome and gut microbiota, which have been shown to play a crucial role in the pathophysiology of MDD, may also participate in the antidepressant-like effects of both ketamine and agmatine. This review seeks to provide evidence about the mechanisms that may underlie the fast antidepressant-like responses of agmatine in preclinical studies. Considering the anti-inflammatory properties of agmatine, it may also be further investigated as a useful compound for the management of MDD associated with a pro-inflammatory state. Moreover, the fast antidepressant-like response of agmatine noted in animal models should be investigated in clinical studies. 相似文献
45.
46.
J. Barnett I. Pulzato M. Javed Y.J. Lee A. Choraria S.V. Kemp A. Rice S. Jordan P.L. Shah A.G. Nicholson S. Padley A. Devaraj 《Clinical radiology》2021,76(1):77.e9-77.e15
47.
L.S. Becker S.K. Maschke C.L.A. Dewald T.C. Meine H.B.M. Winther M.M. Kirstein R. Kloeckner B.C. Meyer F. Wacker J.B. Hinrichs 《Clinical radiology》2021,76(2):160.e27-160.e33
48.
49.
50.
José-Luis Andréu María Auxiliadora Martín Héctor Corominas José Javier Pérez-Venegas José Andrés Román-Ivorra Fernando Sánchez-Alonso Ángel Gil de Miguel 《Reumatología clinica》2021,17(4):212-214
IntroductionThe current paradigm of the management of rheumatoid arthritis (RA) recommends achieving a state of remission or low disease activity through the treat-to-target strategy. Our study assesses adherence to this strategy.MethodPatients with RA (ACR-EULAR 2010 criteria) were included. From each centre, 19 patients were randomly selected. Clinical histories (CH) were assessed by independent auditors, checking compliance with predefined quality criteria. The study was approved by ethics committees.ResultsWe included 856 patients (mean age 54 years; 71% women). The use of a combined index (CI) was recorded in 61% of cases. Visits were recorded every 4 weeks using a CI in 4% of CH while attempts were made to achieve remission. Monitoring of disease activity every 6–8 months after reaching the target was recorded in 73% of cases.ConclusionsThe implementation of the treat-to-target strategy is barely recorded in patients with RA in routine clinical practice. 相似文献